Company / Gross Profit per Share
10x Genomics, Inc. Gross Profit per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$3.63
FY2025
5-year range
$3.48 / $3.84
FY2021-FY2025
Trend
+4.3%
vs FY2024
Sector context
#77 of 94
Health Care
What the data says
10x Genomics, Inc.'s gross profit per share of $3.63 is lower than 82% of companies in the Health Care sector (FY2025). Gross Profit per Share has fluctuated over the past 9 years, ranging from $2.50 in FY2020 to $12.71 in FY2019.
Based on SEC 10-K filings.
3.63 in FY2025 with a 5-year CAGR of +7.8%.
Improved from $3.55 to $3.63 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +1.0%
- 5-Year CAGR
- +7.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 94This company $3.63 Sector average $14.29
▼
-74.6% below sector average
Key checks
Key Insights
- In FY2025, gross profit per share increased 4.3% year-over-year.
- Ranks #77 out of 94 companies in the Health Care sector.
- Peak gross profit per share was recorded in FY2019.
- Lowest gross profit per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.63 | +4.3% |
| FY2024 | $3.48 | -2.1% |
| FY2023 | $3.55 | +1.0% |
| FY2022 | $3.52 | -8.3% |
| FY2021 | $3.84 | +53.7% |
| FY2020 | $2.50 | -80.3% |
| FY2019 | $12.71 | +44.6% |
| FY2018 | $8.79 | +68.2% |
| FY2017 | $5.22 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026